-
1
The Role of TIM-3 in Glioblastoma Progression
Published 2025-02-01Subjects: “…TIM-3…”
Get full text
Article -
2
New perspectives in the treatment of patients with intermediate-2 and high-risk myelodysplastic syndrome
Published 2022-11-01Subjects: Get full text
Article -
3
Tim-3 pathway dysregulation and targeting in sepsis-induced immunosuppression
Published 2024-12-01Subjects: Get full text
Article -
4
The immune checkpoint LAG-3 is expressed by melanoma cells and correlates with clinical progression of the melanoma
Published 2025-12-01Subjects: Get full text
Article -
5
Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation
Published 2024-10-01Subjects: “…TIM-3…”
Get full text
Article -
6
Expression of Tim-3 on neutrophils as a novel indicator to assess disease activity and severity in ankylosing spondylitis
Published 2025-03-01Subjects: Get full text
Article -
7
AI-enhanced profiling of phage-display-identified anti-TIM3 and anti-TIGIT novel antibodies
Published 2025-03-01Subjects: Get full text
Article -
8
Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
Published 2023-05-01Subjects: Get full text
Article -
9
Comprehensive immune profiling and predictive modelling of paediatric acute hepatitis of unknown aetiology from a Spanish cohort
Published 2025-06-01Subjects: Get full text
Article -
10
Immune biomarkers in circulating cells of NSCLC patients can effectively evaluate the efficacy of chemotherapy combined with anti-PD-1 therapy
Published 2025-04-01Subjects: Get full text
Article -
11
TIM‐3 as a potential exhaustion marker in CD4+ T cells of COVID‐19 patients
Published 2021-12-01Subjects: Get full text
Article -
12
-
13
Comprehensive immune ageing reveals TREM2/TIM3 myeloid cells drive brain immune evasionResearch in context
Published 2025-08-01Subjects: Get full text
Article -
14
Blocking Tim-3 enhances CD8+ T cell activity to inhibit hepatocellular carcinoma recurrence post-radiofrequency ablation
Published 2025-12-01Subjects: Get full text
Article -
15
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine
Published 2025-09-01Subjects: Get full text
Article -
16
Development of a preclinical model of myeloid tumors with high immune checkpoints expression
Published 2024-12-01Subjects: “…tim3…”
Get full text
Article -
17
Expression of inhibitory receptors PD-1, CTLA-4, and Tim-3 by peripheral T cells during pregnancy
Published 2022-10-01Subjects: Get full text
Article -
18
Integrated computational and experimental identification of N-[(1H-1,2,4-triazol-3-yl)phenyl]-1-(1H-pyrazolo[3,4-b]pyridin-3-yl)methanamide as a potent and selective TIM-3 inhibito...
Published 2025-06-01Subjects: “…TIM-3…”
Get full text
Article -
19
The Functional Role and Prognostic Significance of TIM-3 Expression on NK Cells in the Diagnostic Bone Marrows in Acute Myeloid Leukemia
Published 2024-11-01Subjects: Get full text
Article -
20
Expression of inhibitory receptors on peripheral blood T cells in pregnant women with preeclampsia
Published 2023-11-01Subjects: Get full text
Article